Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Jun-24 4:26 PM View:  | Ginkgo Bioworks Holdings, I... (DNA) | 12-Jun-24 | Option Exercise | 105,263 | -- | -- | 18% 589.66K to 694.92K | |
| 20-May-24 9:33 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-May-24 | Grant Duplicate | 344,828 | $2.90 | $1,000,000.00 | 4% 8.57M to 8.92M | |
| 20-May-24 9:33 PM View: | Allogene Therapeutics, Inc. (ALLO) | 16-May-24 | Purchase | 1,724,140 | $2.90 | $5,000,000.00 | 19% 8.91M to 10.64M | |
| 31-Jan-24 5:46 PM View: | Allogene Therapeutics, Inc. (ALLO) | 25-Jan-24 | Grant | 211,973 | -- | -- | 3% 8.36M to 8.57M | |
| 24-Mar-23 8:14 PM View: | Allogene Therapeutics, Inc. (ALLO) | 22-Mar-23 | Grant | 1,282,980 | -- | -- | 18% 7.08M to 8.36M | |
| 16-Sep-22 3:13 PM View: | Urogen Pharma Ltd. (URGN) | 14-Sep-22 | Option Exercise | 160,000 | $5.00 | $800,000.00 | 64% 248.69K to 408.69K | |
| 02-Sep-22 11:40 AM View: | Urogen Pharma Ltd. (URGN) | 31-Aug-22 | Option Exercise | 3,241 | $5.00 | $16,205.00 | 1% 245.45K to 248.69K | |
| 13-Jun-22 9:13 PM View: | Ginkgo Bioworks Holdings, I... (DNA) | 10-Jun-22 | Grant | 70,921 | -- | -- | 14% 518.74K to 589.66K | |
| 31-Mar-22 5:27 PM View: | Allogene Therapeutics, Inc. (ALLO) | 14-Mar-22 | Acquisition (other) | 4,710,120 | -- | -- | 67% 7.08M to 11.79M | |
| 31-Mar-22 5:27 PM View: | Allogene Therapeutics, Inc. (ALLO) | 14-Mar-22 | Disposition (other) | 4,710,120 | -- | -- | (40%) 11.79M to 7.08M | |
| 14-Jan-22 12:02 PM View: | Allogene Therapeutics, Inc. (ALLO) | 12-Jan-22 | Market Purchase | 155,039 | $12.60 | $1,953,490.00 | 2% 6.92M to 7.08M | (3%) |
| 25-May-21 8:00 AM View: | Allogene Therapeutics, Inc. (ALLO) | 24-May-21 | Option Exercise | 379,066 | $18.22 | $6,906,580.00 | 6% 6.54M to 6.92M | |
| 30-Mar-21 10:00 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Mar-21 | Grant | 53,635 | -- | -- | < 1% 6.49M to 6.54M | |
| 22-Apr-21 5:19 PM View: | Urogen Pharma Ltd. (URGN) | 24-Mar-21 | Option Exercise | 3,241 | $5.00 | $16,205.00 | 1% 242.21K to 245.45K | |
| 16-Oct-20 3:44 PM View: | Kronos Bio, Inc. (KRON) | 14-Oct-20 | Conversion | 2,739,050 | $1.49 | $4,090,000.00 | 1071% 255.84K to 2.99M | |
| 04-Jun-20 4:04 PM View: | Allogene Therapeutics, Inc. (ALLO) | 04-Jun-20 | Market Purchase | 146,382 | $47.00 | $6,879,950.00 | 2% 6.34M to 6.49M | (41%) |
| 15-May-19 5:10 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-May-19 | Acquisition (other) | 13,413 | -- | -- | < 1% 11.44M to 11.46M | |
| 15-May-19 5:10 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-May-19 | Disposition (other) | 598,935 | -- | -- | (5%) 11.46M to 10.86M | |
| 30-Apr-19 7:21 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Apr-19 | Acquisition (other) | 13,413 | -- | -- | < 1% 12.03M to 12.04M | |
| 30-Apr-19 7:21 PM View: | Allogene Therapeutics, Inc. (ALLO) | 26-Apr-19 | Disposition (other) | 598,937 | -- | -- | (5%) 12.04M to 11.44M | |
| 28-Mar-19 4:52 PM View: | Urogen Pharma Ltd. (URGN) | 27-Mar-19 | Option Exercise | 128,000 | $4.02 | $514,560.00 | 152% 84.21K to 212.21K | |
| 15-Mar-19 5:20 PM View: | Allogene Therapeutics, Inc. (ALLO) | 13-Mar-19 | Grant | 115,333 | -- | -- | < 1% 11.91M to 12.03M | |
| 17-Oct-18 5:29 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Conversion | 7,628,940 | -- | -- | 188% 4.06M to 11.68M | |
| 17-Oct-18 5:29 PM View: | Allogene Therapeutics, Inc. (ALLO) | 15-Oct-18 | Purchase | 35,000 | $18.00 | $630,000.00 | < 1% 11.68M to 11.72M | |
| 05-Oct-17 8:10 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 159,160 | -- | -- | (5%) 3.36M to 3.2M | |
| 05-Oct-17 8:10 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 3,197,270 | $180.00 | $575,507,968.00 | (100%) 3.2M to 0 | |
| 27-Sep-17 9:38 PM View: | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant | 50,000 | -- | -- | 2% 3.28M to 3.33M | |
| 05-Oct-17 8:10 PM View: | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Grant Duplicate | 50,000 | -- | -- | 2% 3.31M to 3.36M | |
| 27-Sep-17 9:38 PM View: | Kite Pharma, Inc. (KITE) | 25-Sep-17 | Market Sale | 26,347 | $179.66 | $4,733,600.00 | (< 1%) 3.33M to 3.31M | (< 1%) |
| 09-May-17 3:37 PM View: | Kite Pharma, Inc. (KITE) | 09-May-17 | Market Purchase | 17,000 | $68.57 | $1,165,690.00 | < 1% 3.27M to 3.28M | 162% |
| 29-Dec-16 5:50 PM View: | Kite Pharma, Inc. (KITE) | 27-Dec-16 | Grant | 43,800 | -- | -- | 1% 3.22M to 3.27M | |
| 22-Dec-16 4:47 PM View: | Kite Pharma, Inc. (KITE) | 20-Dec-16 | Market Sale | 3,493 | $50.86 | $177,654.00 | (< 1%) 3.29M to 3.29M | (240%) |
| 29-Dec-16 5:50 PM View: | Kite Pharma, Inc. (KITE) | 09-Dec-16 | Gift | 66,000 | -- | -- | (2%) 3.29M to 3.22M | |
| 17-Aug-16 6:03 PM View: | Arno Therapeutics, Inc (ARNI) | 15-Aug-16 | Purchase Duplicate | 714,285 | -- | -- | 22% 3.22M to 3.93M | |
| 14-Jan-16 5:19 PM View: | Arno Therapeutics, Inc (ARNI) | 12-Jan-16 | Purchase | 2,162,350 | $0.35 | $756,821.00 | 205% 1.06M to 3.22M | |
| 12-Feb-16 4:45 PM View: | Kite Pharma, Inc. (KITE) | 21-Dec-15 | Gift | 541,722 | -- | -- | (14%) 3.83M to 3.29M | |
| 21-Dec-15 8:34 PM View: | Kite Pharma, Inc. (KITE) | 17-Dec-15 | Grant | 28,200 | -- | -- | < 1% 5.5M to 5.53M | |
| 12-Feb-16 4:45 PM View: | Kite Pharma, Inc. (KITE) | 10-Dec-15 | Gift | 458,324 | -- | -- | (11%) 4.29M to 3.83M | |
| 12-Feb-16 4:45 PM View: | Kite Pharma, Inc. (KITE) | 07-Oct-15 | Gift | 1,240,000 | -- | -- | (22%) 5.53M to 4.29M | |
| 01-Aug-14 2:10 PM View: | Kite Pharma, Inc. (KITE) | 25-Jun-14 | Conversion | 1,529,560 | -- | -- | 38% 3.97M to 5.5M | |
| 05-Nov-13 10:08 AM View: | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 21,666 | $2.40 | $51,998.40 | 29% 74.78K to 96.44K | |
| 05-Nov-13 10:08 AM View: | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Grant | 11,666 | $2.40 | $27,998.40 | 47% 24.6K to 36.27K | |
| 05-Nov-13 10:08 AM View: | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 288,828 | $2.40 | $693,187.00 | 299% 96.44K to 385.27K | |
| 05-Nov-13 10:08 AM View: | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Conversion | 155,523 | $2.40 | $373,255.00 | 429% 36.27K to 191.79K | |
| 05-Nov-13 10:08 AM View: | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 395,832 | -- | -- | 103% 385.27K to 781.11K | |
| 05-Nov-13 10:08 AM View: | Arno Therapeutics, Inc (ARNI) | 29-Oct-13 | Purchase | 83,332 | -- | -- | 43% 191.79K to 275.13K | |
| 03-Jun-13 4:46 PM View: | Arno Therapeutics, Inc (ARNI) | 28-May-13 | Acquisition (other) | 64,445 | $0.30 | $19,333.50 | 9% 730.65K to 795.09K | |
| 07-May-13 12:20 PM View: | Arno Therapeutics, Inc (ARNI) | 29-Apr-13 | Acquisition (other) | 66,666 | $0.30 | $19,999.80 | 10% 663.98K to 730.65K | |
| 15-Apr-13 9:32 AM View: | Arno Therapeutics, Inc (ARNI) | 27-Mar-13 | Acquisition (other) Duplicate | 66,666 | $0.30 | $19,999.80 | 11% 597.32K to 663.98K | |
| 07-Jul-09 4:04 PM View: | Cougar Biotechnology, Inc. (CGRB) | 03-Jul-09 | Disposition (change in control) | 307,668 | $43.00 | $13,229,700.00 | (86%) 357.33K to 49.66K | < 1% |